AVIRON
S-8, EX-5.1, 2000-08-23
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: AVIRON, S-8, 2000-08-23
Next: AVIRON, S-8, EX-23.1, 2000-08-23



<PAGE>   1

                                                                     EXHIBIT 5.1

                        [COOLEY GODWARD LLP LETTERHEAD]


August 23, 2000



Aviron
297 North Bernardo Avenue
Mountain View, CA 94043

Ladies and Gentlemen:

You have requested our opinion with respect to certain matters in connection
with the filing by Aviron (the "Company") of a Registration Statement on Form
S-8 (the "Registration Statement") with the Securities and Exchange Commission
covering the offering of (i) up to 2,150,000 shares of the Company's Common
Stock, $.001 par value, (the "Shares") pursuant to its 1996 Equity Incentive
Plan (the "Incentive Plan"), its 1996 Non-Employee Directors' Stock Option Plan
(the "Option Plan"), and its 1999 Non-Officer Equity Incentive Plan (the
"Non-Officer Plan") and (ii) up to 575,144 shares of the Company's Common Stock,
$.001 par value, (the "C. Boyd Clarke Shares"), issuable in connection with the
stock option grants to C. Boyd Clarke outside of a plan (the "C. Boyd Clarke
Options").

In connection with this opinion, we have examined the Registration Statement and
related Prospectuses, your Certificate of Incorporation and By-laws, as amended,
and such other documents, records, certificates, memoranda and other instruments
as we deem necessary as a basis for this opinion. We have assumed the
genuineness and authenticity of all documents submitted to us as originals, the
conformity to originals of all documents submitted to us as copies thereof, and
the due execution and delivery of all documents where due execution and delivery
are a prerequisite to the effectiveness thereof.

On the basis of the foregoing, and in reliance thereon, we are of the opinion
that the Shares, when sold and issued in accordance with the Incentive Plan, the
Option Plan, the Non-Officer Plan, the Registration Statement and related
Prospectuses, will be validly issued, fully paid, and nonassessable (except as
to shares issued pursuant to certain deferred payment arrangements, which will
be fully paid and nonassessable when such deferred payments are made in full).
In addition, we are of the opinion that the C. Boyd Clarke Shares, when sold and
issued in accordance with the C. Boyd Clarke Options, the Registration Statement
and related Prospectus, will be validly issued, fully paid, and nonassessable
(except as to shares issued pursuant to certain deferred payment arrangements,
which will be fully paid and nonassessable when such deferred payments are made
in full).

We consent to the filing of this opinion as an exhibit to the Registration
Statement.

Very truly yours,

COOLEY GODWARD LLP


By: /s/ Robert J. Brigham
   ----------------------
   Robert J. Brigham


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission